Glucosamine
Glucosamine is a naturally occurring amino sugar that is a building block of the cartilage matrix. It is sold in two distinct UK regulatory categories: as a food supplement (where it has no authorised UK health claims) and as a UK Pharmacy Medicine (P) for symptomatic relief of mild to moderate osteoarthritis of the knee under licensed indications. The food-supplement category is what most consumers encounter on-shelf and online; this entry focuses on it. Most commercial supplements pair glucosamine with chondroitin and / or MSM — see those entries for component detail.
Camden Medicals editorial · Last reviewed 1 May 2026 · Next review November 2026
- Cross-checked against
- NHS
- NICE
- BNF
- EFSA
- FSA
Camden's editorial team independently graded each health claim below on the strength of the published evidence — see the grade beside every condition.
- Class
- Amino acid
- Typical daily dose
- 1500 mg/day glucosamine sulphate (taken as 1500 mg once daily or split as 500 mg three times daily) — the dose used in the UK Pharmacy Medicine licensing and in most osteoarthritis trials. Glucosamine HCl supplements at the same labelled milligram deliver similar free glucosamine, with a weaker trial base.
- Top use evidence
- Moderate
On this page
What it is
Glucosamine is an amino sugar — formally 2-amino-2-deoxy-D-glucose — and is a building block of glycosaminoglycans (GAGs) and proteoglycans in connective tissue, cartilage, and synovial fluid. Endogenous glucosamine is synthesised from glucose and glutamine via the hexosamine biosynthesis pathway; dietary contributions from food are minimal. Commercial glucosamine for supplements is typically extracted from the chitin in crustacean shells (shrimp, crab, lobster) — relevant for shellfish allergy. Plant-fermented vegan glucosamine, made by Aspergillus niger fermentation, is also commercially available.
Two salt forms dominate the market: glucosamine sulphate (often stabilised with potassium chloride or sodium chloride, hence "glucosamine sulphate KCl / NaCl") and glucosamine hydrochloride. The two forms deliver similar amounts of free glucosamine on a molar basis but the trial evidence base differs: glucosamine sulphate (especially the patented Rotta crystalline glucosamine sulphate, 1500 mg/day) is what the better osteoarthritis trials have used and is the form licensed as a UK P medicine. Glucosamine HCl, more common in food supplements, has a weaker and less consistent trial evidence base.
At a glance
- A naturally occurring amino sugar and a building block of cartilage; the body makes its own, and food contributes little.
- No UK-authorised health claim as a food supplement — EFSA did not substantiate claims for glucosamine and joint or cartilage health.
- Glucosamine SULPHATE (1500 mg/day) is licensed in the UK as a Pharmacy Medicine (P) for symptomatic mild-to-moderate knee osteoarthritis — a regulated-medicine context, separate from the food supplement most products sit in. Glucosamine HYDROCHLORIDE (HCl), common in supplements, has a weaker trial base.
- NICE osteoarthritis guidance (NG226) advises against offering glucosamine and does not recommend chondroitin; most products combine glucosamine with chondroitin and / or MSM.
What people use it for
Adults with mild-to-moderate knee osteoarthritis exploring symptomatic options
Glucosamine sulphate is licensed as a UK Pharmacy Medicine for this indication. Glucosamine HCl food supplements are not licensed for it. NICE NG226 does not recommend either as part of standard osteoarthritis management. Talk to your GP / pharmacist about evidence-based options including topical NSAIDs, paracetamol, exercise, weight management, and physiotherapy. [3,1]
Popular, not provenMixedAdults with rheumatoid arthritis, gout, or other inflammatory joint disease
Glucosamine has not been shown effective for these conditions. UK NHS pathways for inflammatory arthritis (DMARDs, biologics, urate-lowering therapy in gout) apply. [8,9]
Popular, not provenInsufficientAdults wanting "joint maintenance" without diagnosed arthritis
No food-supplement health claim is authorised in the UK. Lifestyle measures with established evidence — strength training, weight management, balanced diet — are the more reliable path to joint health. [10]
Popular, not provenInsufficientAdults with shellfish allergy
Most commercial glucosamine is extracted from crustacean shells. Glucosamine itself is not the major allergen but contamination with shellfish protein during processing has been documented in some products. If you have a shellfish allergy, vegan glucosamine (from Aspergillus niger fermentation) is the safer category. Talk to your pharmacist.
Some evidenceLimitedAdults taking warfarin
Talk to your pharmacist or anticoagulation team. Multiple post-marketing reports describe INR rises with glucosamine + warfarin combination. Mechanism is uncertain but the interaction is real enough to warrant additional INR monitoring or avoiding glucosamine. [4]
Some evidenceModerate
How it works
Multiple mechanisms have been proposed. Direct anabolic stimulation of chondrocyte cartilage-matrix synthesis (proteoglycan, GAG, collagen) is the classical mechanism, supported by laboratory work but not by consistent in-vivo cartilage-imaging changes in humans. Anti-inflammatory effects on cartilage-degrading enzymes have also been described in laboratory studies. The clinical translation in human osteoarthritis is contested: trial effect sizes on pain and function are heterogeneous, several large independent trials (notably GAIT) have been negative, and NICE osteoarthritis guidance does not recommend glucosamine.
Common myths
Myth"Glucosamine rebuilds cartilage"
RealityCartilage matrix synthesis happens in chondrocytes; whether oral glucosamine meaningfully accelerates that process in vivo is uncertain. Cartilage-imaging changes in trials have been small and inconsistent. The "rebuilds cartilage" framing exceeds what the evidence supports and exceeds what UK supplement-marketing rules permit.
Myth""Natural therefore safe" — glucosamine is fine for everyone"
RealityIt has documented interactions (warfarin, possibly others), documented contraindications (severe shellfish allergy in animal-sourced products), and remains contraindicated in pregnancy / breastfeeding due to limited safety data. Natural origin is not a clinical reasoning standard.
Myth"Higher dose works better"
RealityThe evidence-based dose is 1500 mg/day glucosamine sulphate. Higher doses do not have stronger evidence and increase the rate of GI complaints. Multiple-times-daily dosing is largely about pill-burden, not pharmacokinetics.
Common online questions
Synthesised from the questions UK shoppers most often ask online about Glucosamine. Each answer is editorial and links to its evidence in the Sources list below.
Is glucosamine sulphate better than glucosamine HCl?
For trial evidence and UK regulatory status, yes. The UK-licensed Pharmacy Medicine for osteoarthritis is glucosamine sulphate at 1500 mg/day — that is the form and dose with the more consistent trial evidence. Glucosamine HCl, more common in food supplements, has a weaker and less consistent trial base. On a per-milligram basis the two forms deliver similar free glucosamine, but the regulatory history sits with sulphate. [3]
Should I take glucosamine + chondroitin together or separately?
Most commercial products combine the two (often with MSM). The large GAIT trial tested glucosamine alone, chondroitin alone, and the combination, and found no significant benefit over placebo at the primary endpoint. NICE osteoarthritis guidance does not recommend the combination. There is no strong evidence the combination is meaningfully better than either alone.
Will glucosamine raise my blood sugar or affect diabetes?
Glucosamine is a glucose-derived molecule and early laboratory studies suggested possible insulin-resistance effects. Multiple clinical trials in people with type 2 diabetes have NOT shown meaningful changes in HbA1c at standard supplement doses. Disclose all supplements to your diabetes team if you take prescribed glycaemic medication.
I'm on warfarin — is glucosamine OK?
Talk to your anticoagulation team first. Multiple post-marketing reports describe INR rises with glucosamine + warfarin combination. The mechanism is not fully understood, but the interaction is real enough that BNF flags it. Standard practice is either to avoid glucosamine on warfarin or to add INR monitoring around any change. [4,3]
I have a shellfish allergy — can I take glucosamine?
Most commercial glucosamine is extracted from crustacean shells. Glucosamine itself is not the major allergen, but contamination during processing has been documented in some products. If you have a shellfish allergy, vegan glucosamine (made by Aspergillus niger fermentation) is the safer category — read the label. If your shellfish reaction has ever been severe, talk to your pharmacist before any glucosamine supplement.
🔬 Camden’s evidence review
The research Camden reviewed, graded on its strength. This is our own appraisal — it sits beneath the official guidance above, never above it.
Knee osteoarthritis — pain and function
MixedEvidencemixedTrials of crystalline glucosamine sulphate at 1500 mg/day have reported small-to-moderate improvements in pain and function in knee osteoarthritis in some studies, with effect sizes that have not consistently replicated in larger independent trials. The large NIH-funded GAIT trial reported no overall benefit of glucosamine HCl, chondroitin, or the combination over placebo at the primary endpoint. Cochrane reviews have classified glucosamine evidence as "low certainty" overall. NICE osteoarthritis guidance does not recommend glucosamine. [11]
Cartilage structure / disease modification
LimitedEvidencelimitedSome imaging studies of glucosamine sulphate have reported small effects on joint-space narrowing over multi-year follow-up. Independent replication and clinical translation to long-term outcomes have been limited.
Hip and other joint osteoarthritis
InsufficientEvidenceinsufficientTrial evidence outside the knee is limited and inconsistent.
Safety
Glucosamine is well-tolerated for most adults at 1500 mg/day. The two clinical concerns are the warfarin interaction and shellfish allergy in animal-sourced products. UK NICE osteoarthritis guidance does not recommend glucosamine.
Talk to your pharmacist or GP first if you:
- You take warfarin or another vitamin-K antagonist — INR rises have been reported.
- You have a shellfish allergy and the product is animal-sourced.
- You take diabetes medication — disclose all supplements; standard-dose glucosamine has not shown meaningful glycaemic effects in trials but disclosure matters.
- You are pregnant, breastfeeding, or trying to conceive — limited safety data.
- You have asthma — case reports of asthma flare with glucosamine supplementation exist (mechanism uncertain).
Common side effects: Mild GI complaints (nausea, abdominal discomfort, diarrhoea, constipation, heartburn) — typically dose-related and resolve on reduction.
Pregnancy and breastfeeding
Limited safety data in pregnancy; standard advice is to avoid glucosamine supplementation in pregnancy. Talk to your pharmacist or GP.
Limited safety data; avoid.
Talk to your GP, midwife, or pharmacist before starting any supplement during pregnancy or breastfeeding.
More clinical detail (for clinicians and informed readers)
Contraindications
- Severe shellfish allergy with shellfish-derived products.
- Pregnancy and breastfeeding (precautionary — limited data).
- Known hypersensitivity to glucosamine or supplement constituents.
Drug interactions
- Warfarin — INR rises reported in case series; BNF-flagged. Monitor INR around any change.
- Diabetes medication — disclose use; standard-dose glucosamine has not shown meaningful glycaemic effects in trials but standard practice is disclosure.
This is not an exhaustive list. Always tell your prescriber and pharmacist about every supplement you take.
Common side effects
- Mild GI complaints — nausea, abdominal discomfort, diarrhoea, heartburn.
- Headache.
Rare side effects
- Allergic reactions — particularly in shellfish-allergic individuals taking shellfish-derived products.
- Asthma exacerbation — case reports.
- Photosensitivity — rare reports.
How to take it
- Typical supplemental range
- 1500 mg/day glucosamine sulphate (taken as 1500 mg once daily or split as 500 mg three times daily) — the dose used in the UK Pharmacy Medicine licensing and in most osteoarthritis trials. Glucosamine HCl supplements at the same labelled milligram deliver similar free glucosamine, with a weaker trial base.
- Timing
- Daily — split with meals if GI complaints occur.
How to spot quality
Look for
- Form clearly named: glucosamine sulphate (potassium chloride or sodium chloride stabilised) vs glucosamine HCl. Sulphate is what the licensed P-medicine and the better trials used.
- mg of glucosamine equivalent per serving stated, not just "glucosamine complex".
- Source disclosure: shellfish-derived vs vegan (Aspergillus niger fermentation).
- GMP-certified manufacture.
- For combination products: per-component dose breakdown (chondroitin / MSM separately listed).
Red flags
- Marketed for "rebuilding cartilage" / "reversing arthritis" / "joint regeneration".
- "Joint complex" with glucosamine hidden in a proprietary blend.
- No source disclosure (shellfish vs vegan).
- Marketed alongside warfarin advice without prominent interaction warnings.
- Comparison to NSAIDs without acknowledging UK-authorised vs unlicensed status.
Commonly combined with
Other ingredients that share a biological pathway, cofactor relationship, or evidence-backed protocol with this one. Mechanisms below cite primary physiology — not folk pairing. Doses are literature ranges, not recommendations. Talk to your pharmacist or GP before changing your stack, especially if you take prescription medication.
Chondroitin Sulphate
Mixed evidenceGlucosamine and chondroitin are commonly co-administered for knee osteoarthritis; the combination is the most-studied joint-supplement stack.
Glucosamine sulphate is a substrate for the synthesis of glycosaminoglycans, the structural component of cartilage matrix. Chondroitin sulphate is itself a glycosaminoglycan and is hypothesised to inhibit cartilage-degrading enzymes (cathepsins, matrix metalloproteinases). The mechanistic rationale for combining them is that glucosamine provides building blocks for new GAGs while chondroitin slows the breakdown of existing matrix. Clinical evidence from the largest combination trial (GAIT) is best characterised as mixed: no statistically significant benefit on the primary endpoint in the overall population, but a pre-specified subgroup with moderate-to-severe knee pain showed a clinically meaningful response.
Evidence: Clegg 2006 (GAIT, NEJM 354:795) randomised 1,583 adults with symptomatic knee osteoarthritis to 1,500 mg glucosamine + 1,200 mg chondroitin sulphate, either alone, the combination, celecoxib 200 mg, or placebo for 24 weeks. Primary endpoint (>=20% pain reduction) was not significantly improved by either supplement or the combination versus placebo (60.1% response in the overall placebo group). The pre-specified moderate-to-severe pain subgroup did show a significant combination effect (79.2% vs 54.3%, p=0.002). Subsequent meta-analyses have variously supported and rejected the combination; effect sizes are small. [12]
Doses studied: GAIT-trial doses: 1,500 mg glucosamine sulphate + 1,200 mg chondroitin sulphate daily, in divided doses with meals.
Green-Lipped Mussel (Perna canaliculus)
Limited evidenceJoint-cluster pairing — GLM + glucosamine combination products (Brien 2008 Cochrane mixed).
GLM lipid anti-inflammatory + glucosamine GAG substrate. Different mechanisms; complementary.
Evidence: Green-lipped mussel (an omega-3/GAG-bearing extract) and glucosamine are sometimes combined for joint comfort, but the pairing has no UK guideline backing and no authorised joint health claim; evidence for either remains limited.
Doses studied: 1000 mg GLM extract + 1500 mg glucosamine sulphate daily.
MSM (Methylsulfonylmethane)
Mixed evidenceThe classic UK joint-supplement combination — glucosamine + chondroitin + MSM is the most-marketed joint-cluster trio.
Glucosamine glycosaminoglycan substrate; chondroitin sulphated GAG matrix component; MSM organic-sulphur cofactor for connective-tissue methionine cycle + modest anti-inflammatory. Mechanism complementary on joint-matrix axis.
Evidence: Cochrane reviews mixed; UK NICE NG226 OA pathway does not include either.
Doses studied: 1500 mg glucosamine sulphate + 1200 mg chondroitin + 1000-3000 mg MSM daily.